Apimeds Pharmaceuticals US (APUS) Price: 4.60

Apimeds Pharmaceuticals US, Inc. (APUS)

4.60 -0.02 (-0.43%) USD | NYAM | Oct 14, 10:11

Price Chart

Historical Price Data

View and export this data back to 2025. Start Trial.

Date	Open	High	Low	Close	Volume
Oct 13, 2026	4.87	4.91	4.26	4.62	341943.0
Oct 12, 2026	5.43	6.036	4.971	5.20	1.404M
Oct 09, 2026	5.54	5.72	4.40	5.02	3.346M
Oct 08, 2026	6.43	6.496	5.210	5.51	1.113M
Oct 07, 2026	8.00	9.84	6.86	7.05	22.40M
Oct 06, 2026	4.91	8.39	4.71	7.13	43.84M
Oct 05, 2026	4.99	5.83	4.21	4.59	33.79M
Oct 02, 2026	4.10	4.16	3.10	3.22	138716.0
Oct 01, 2026	4.90	5.09	4.10	4.10	146511.0
Sep 30, 2026	5.04	5.25	4.72	5.00	191508.0
Sep 29, 2026	6.17	6.17	4.63	5.02	768441.0
Sep 28, 2026	6.33	6.50	5.56	6.39	858796.0
Sep 25, 2026	8.32	9.14	5.39	7.25	37.11M
Sep 24, 2026	6.99	8.74	4.61	4.92	87.85M
Sep 23, 2026	1.81	2.30	1.745	2.29	152528.0
Sep 22, 2026	1.65	1.999	1.613	1.85	134824.0
Sep 21, 2026	1.72	1.865	1.67	1.67	671015.0
Sep 18, 2026	1.68	2.10	1.630	1.77	1.336M
Sep 17, 2026	1.73	1.92	1.60	1.67	83999.00
Sep 16, 2026	1.71	1.71	1.51	1.60	65032.00
Sep 15, 2026	2.11	2.110	1.60	1.64	66300.00
Sep 14, 2026	2.39	2.39	2.025	2.09	29815.00
Sep 11, 2026	2.16	2.26	2.09	2.105	20691.00
Sep 10, 2026	2.26	2.47	2.12	2.17	41162.00
Sep 09, 2026	2.30	2.35	2.17	2.29	29573.00

Price Definition

The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).

Read full definition.

Price Range, Past 5 Years

View Price Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

Price Benchmarks

View Price Benchmarks